Life expectancy and health expenditure evolution in Eastern Europe—DiD and DEA analysis

Expert Review of Pharmacoeconomics and Outcomes Research

Volumn 16, Issue 4, 2016, Pages 537-546

  Jakovljevic, Mihajlo B ^a   Vukovic, Mira ^b   Fontanesi, John ^c  

^a University of Kragujevac Medical Faculty   (Serbia)

^b Health Center Valjevo   (Serbia)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

CIS; EU; health expenditure; life expectancy; long term trends; longevity; SEE; Socioeconomic transition

Indexed keywords

DATA BASE; LIFE EXPECTANCY; LONGEVITY; COST; EASTERN EUROPE; FACTUAL DATABASE; HEALTH CARE COST; HUMAN; RETROSPECTIVE STUDY; TRENDS;

COSTS AND COST ANALYSIS; DATABASES, FACTUAL; EUROPE, EASTERN; HEALTH EXPENDITURES; HUMANS; LIFE EXPECTANCY; LONGEVITY; RETROSPECTIVE STUDIES;

EID: 84950139756     PISSN: 14737167     EISSN: 17448379     Source Type: Journal    
DOI: 10.1586/14737167.2016.1125293     Document Type: Article

References (38)

1. V.Tismaneanu Understanding 1989 the revolutionary tradition revisited. E Eur Polit Soc. 2014;28(4):644–652.
2. M.Tambor, M.Pavlova, B.Rechel, et al. Willingness to pay for publicly financed health care services in Central and Eastern Europe:evidence from six countries based on a contingent valuation method. Soc Sci Med. 2014;116:193–201.
3. G.C.Bentoiu, G.Ghic, C.Athu. The importance of ensuring the zonal comparability of macroeconomic indicators in the study of mass socio:economic phenomena. KHE. 2014;6(2):127–129.
4. V.Pacáková, P.Jindrova. Quantification of selected factors of longevity. In:Recent advances in mathematical methods in applied sciences. Atény:WSEAS Press; 2014. p. 170–174. ISBN 978-1-61804-251-4. [cited 2015 Mar15]. Available from:http://www.europment.org/library/2014/russia/bypaper/MEAS/MEAS-25.pdf.
5. A.Koizumi. Longevity and health care:a cost-benefit type analysis of life expectancy and medical expenditure. Jinkogaku Kenkyu. 1984;7:9–14.
6. R.Aísa, J.Clemente, F.Pueyo. The influence of (public) health expenditure on longevity. Int J Public Health. 2014;59(5):867–875.
7. M.Brusis. Between EU requirements, competitive politics, and national traditions:re-creating regions in the accession countries of central and Eastern Europe. Governance. 2002;15(4):531–559.
8. M.Lechner. The estimation of causal effects by difference-in-difference methods. Found Trends Econ. 2011;4(3):165–224.* Core source of data used in this study - public registry issued and maintained by WHO European Office allowing for international comparability of data.
9. World Health Organization. European Health for All Database (HFA-DB) World Health Organization Regional Office for Europe. [updated 2014 Apr; cited 2015 Mar 15]. Available from:http://data.euro.who.int/hfadb/.
10. L.Kuntz, S.Scholtes, A.Vera. Incorporating efficiency in hospital-capacity planning in Germany. Eur J Health Econ. 2007;8(3):213–223.
11. E.Brainerd, D.M.Cutler Autopsy on an empire:understanding mortality in Russia and the former Soviet Union (No. w10868). National Bureau of Economic Research. [updated 2004 Oct; cited 2015 Mar 15]. Available from:http://www.nber.org/papers/w10868.pdf.
12. M.Jovanovic, M.Jakovljevic. Inpatient detoxification procedure and facilities:financing considerations from an Eastern European perspective. Alcohol Alcohol. 2011;46(3):364–365.
13. J.V.Brown, N.L.Rusinova. Russian medical care in the 1990s:A user’s perspective. Soc Sci Med. 1997;45(8):1265–1276.
14. V.S.Gordeev, M.Pavlova, W.Groot. Two decades of reforms. Appraisal of the financial reforms in the Russian public healthcare sector. Health Policy. 2011;102(2):270–277.
15. C.Hertzman, S.Kelly, M.Bobak. East-West life expectancy gap in Europe:environmental and non-environmental determinants. Vol. 19. The Netherlands:Springer; 1996.
16. J.Reamy, S.Oreskovic. Life expectancy in Central and Eastern European countries and newly inedependent states of the former Soviet Union:changes by gender. Croat Med J. 1999;40(2):237–243.** Crucial research pointing out to the important East-West public health divisions in the European Region.
17. P.Carlson. Self-perceived health in East and West Europe:another European health divide. Soc Sci Med. 1998;46(10):1355–1366.
18. E.Atanasova, M.Pavlova, R.Velickovski, et al. What have 10 years of health insurance reforms brought about in Bulgaria? Re-appraising the Health Insurance Act of 1998. Health Policy. 2011;102(2):263–269.
19. S.Tomini, W.Groot, M.Pavlova. Informal payments and intra-household allocation of resources for health care in Albania. BMC Health Serv Res. 2012;12(1):17.
20. M.Jakovljević, M.Jovanović, Z.Lazić, et al. Current efforts and proposals to reduce healthcare costs in Serbia. Sjecr. 2011;12(4):161–163.
21. T.Petrusic, M.Jakovljevic. Budget impact of publicly reimbursed prescription medicines in the Republic of Srpska. Front Public Health – Epidemiol. 2015. DOI:10.3389/fpubh.2015.00213.
22. C.D.Mathers, R.Sadana, J.A.Salomon, et al. Healthy life expectancy in 191 countries, 1999. Lancet. 2001;357(9269):1685–1691.
23. R.Taylor, G.Salkeld. Health care expenditure and life expectancy in Australia:how well do we perform? Aust N Z J Public Health. 1996;20(3):233–240.
24. E.R.Meara, S.Richards, D.M.Cutler. The gap gets bigger:changes in mortality and life expectancy, by education, 1981–2000. Health Aff (Millwood). 2008;27(2):350–360.
25. K.Taira, H.Tanaka, M.Arakawa, et al. Sleep health and lifestyle of elderly people in Ogimi, a village of longevity. Psychiatry Clin Neurosci. 2002;56(3):243–244.
26. S.Hupfeld. Non-monotonicity in the longevity–income relationship. J Popul Econ. 2011;24(1):191–211.
27. B.Shang, D.Goldman. Does age or life expectancy better predict health care expenditures? Health Econ. 2008;17(4):487–501.
28. A.Kovacevic, V.Dragojevic-Simic, N.Rancic, et al. End-of-life costs of medical care for advanced stage cancer patients. Vojnosanit Pregl. 2015;72(4):334–341.
29. S.Ogura, M.Jakovljevic. Health financing constrained by population aging - an opportunity to learn from Japanese experience. SJECR. 2014;15(4):175–181.** Study essential for the understanding of the causal connection between population aging and medical spending.
30. J.Lubitz, L.Cai, E.Kramarow, et al. Health, life expectancy, and health care spending among the elderly. N Engl J Med. 2003;349(11):1048–1055.** One of the key published evidence on relationship between life expectancy and future health spending.
31. T.B.Bjørner, S.Arnberg. Terminal costs, improved life expectancy and future public health expenditure. Int J Health Care Finance Econ. 2012;12(2):129–143.
32. M.Jakovljevic. The key role of leading emerging BRIC markets for the future of global health care. SJECR. 2014;15(3):139–143.
33. M.B.Jakovljevic. Resource allocation strategies in Southeastern European health policy. Eur J Health Econ. 2013;14(2):153–159.
34. The World Bank. Health status. [cited 2015 Mar 15]. Available from:http://data.worldbank.org/topic/health.
35. World Health Organization. WHO global expenditure database national health accounts. [cited 2015 Mar 15]. Available from:http://www.who.int/health-accounts/ghed/en/.
36. M.Jakovljevic, U.Laaser. Population aging from 1950 to 2010 in seventeen transitional countries in the wider region of South Eastern Europe (Original research). SEEJPH. 2015. [cited 2015 FebXX. DOI:10.12908/SEEJPH-2014-42.* Important insight into the health spending trends among the leading emerging markets most likely to shape global health spending evolution up to 2025.
37. M.B.Jakovljevic. BRIC’s growing share of global health spending and their diverging pathways. Front Public Health. 2015;3:135. DOI:10.3389/fpubh.2015.00135.
38. M.Jakovljevic. Comparison of historical medical spending patterns among the BRICS and G7. J Med Econ. 2015 Sep. DOI:10.3111/13696998.2015.1093493.